Learned marker selection precedes mixed macrophage expression checks
Source check: Source checked. Not independent scientific confirmation.
Finding: LASSO-based selection and network prioritization nominated five periodontitis-associated candidates. A source-reported macrophage comparison found ATF3 and CXCR4 higher, and TXN, CBX3 and MBP lower, at RNA and protein levels. This record represents those expression observations, without adopting a clinical diagnostic test or a causal disease mechanism.
Technology: LASSO feature selection
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- LASSO selects22 expression candidates, followed by protein-network prioritization of five that undergo a new expression check. AI credit is limited to nomination, not downstream causal interpretation.
- Test and result
- Actual computational selection sections and nonactionable expression Results were read. The source reports concordant RNA/protein directions in an inflammatory macrophage comparison.
- Limitation / still unknown
- Operational culture/assay protocols and supplementary replicate details were not inspected. Archived discovery and validation arrays contain repeated gingival sites per patient, with healthy sites within periodontitis patients and possible cohort overlap; another series includes peri-implantitis and a further RNA-sequencing series includes gingivitis. Clinical discrimination, independent patient validation, novel macrophage taxonomy and therapeutic/causal claims are outside the represented result. The reported model C-index is not adopted as an AUC.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12615752/ · https://doi.org/10.1016/j.identj.2025.103983
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Actual relevant primary computational/clinical Methods and high-level Results read; no operational biological protocols inspected.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.